Gilat Captures Greater Maritime Market Share in New Deal with Eurasian Satellite Service Provider
January 13, 2022 07:04 ET
|
Gilat Satellite Networks Ltd.
PETAH TIKVA, Israel, Jan. 13, 2022 (GLOBE NEWSWIRE) -- Gilat Satellite Networks Ltd. (Nasdaq: GILT, TASE: GILT), a worldwide leader in satellite networking technology, solutions, and services,...
Directed IRA Customers Invested Over $40M in Gemini Crypto IRA Solution In First 5 Months
November 17, 2021 09:35 ET
|
Directed IRA
PHOENIX, Nov. 17, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- Since launching its Crypto IRA Solution through a strategic relationship with Gemini in May 2021, Directed IRA has attracted over $40M...
Axsome Therapeutics Presents New Data from GEMINI Phase 3 Trial with AXS-05 Demonstrating Rapid and Significant Improvements in Patient-Reported Outcomes in Major Depressive Disorder
September 14, 2020 06:00 ET
|
Axsome Therapeutics, Inc.
Rapid, durable, and statistically significant improvement demonstrated in patient-reported depressive symptoms, as measured by the QIDS-SR-16 total score compared to placebo (p=0.001) Clinical...
Axsome Therapeutics Completes Successful FDA Pre-NDA Meeting for AXS-05 for the Treatment of Major Depressive Disorder
July 13, 2020 07:00 ET
|
Axsome Therapeutics, Inc.
NDA submission on track for 4Q 2020 NEW YORK, July 13, 2020 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing novel therapies for the management...
Axsome Therapeutics Presents Data from GEMINI Phase 3 Trial of AXS-05 in Major Depressive Disorder at the 2020 American Society for Clinical Psychopharmacology Annual Meeting
May 29, 2020 07:00 ET
|
Axsome Therapeutics, Inc.
NEW YORK, May 29, 2020 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing novel therapies for the management of central nervous system (CNS)...
Announcing ELEV8: Digital Assets, April 14-15 in New York City, led by Anchorage, Morgan Creek Digital, Pantera Capital, NASDAQ, Gemini, Dominion Capital, Kelman PLLC and more
February 18, 2020 15:35 ET
|
ELEV8
New York, NY, Feb. 18, 2020 (GLOBE NEWSWIRE) -- (via Blockchain Wire) ELEV8 announces the first of four events to take place in 2020, ELEV8: Digital Assets. The two day conference will take place...
Axsome Therapeutics Announces AXS-05 Achieves Primary Endpoint in GEMINI Phase 3 Trial in Major Depressive Disorder
December 16, 2019 06:00 ET
|
Axsome Therapeutics, Inc.
Demonstrated rapid, durable, and statistically significant improvement in depressive symptoms as measured by MADRS total score compared to placebo (p=0.002 on primary endpoint) Statistically...
Axsome Therapeutics to Report Third Quarter 2019 Financial Results on November 7, 2019
October 29, 2019 07:00 ET
|
Axsome Therapeutics, Inc.
Axsome to host conference call and webcast on Thursday, November 7, 2019 at 8:00 AM Eastern Time NEW YORK, Oct. 29, 2019 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a...
Axsome Therapeutics Announces Completion of Patient Enrollment in the GEMINI Phase 3 Trial of AXS-05 in Major Depressive Disorder
October 16, 2019 07:00 ET
|
Axsome Therapeutics, Inc.
NEW YORK, Oct. 16, 2019 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a clinical-stage biopharmaceutical company developing novel therapies for the management of central nervous...